Litigation Details for BTcP Pharma v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2017-09-13
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	INSYS THERAPEUTICS, INC.
Patents	10,016,403; 8,486,972; 8,486,973; 8,835,459; 8,835,460; 9,241,935; 9,289,387; 9,642,797; 9,642,844
Attorneys	Tara Mythri Raghavan
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-09-13	1		United States Patent Nos. 8,486,972 (“the ’972 patent”); 8,486,973 (“the ’973 patent”); 8,835,459 (“…(“the ’459 patent”); 8,835,460 (“the ’460 patent”); 9,241,935 (“the ’935 patent”); 9,289,387 (“the ’387…’387 patent”); 9,642,797 (“the ’797 patent”); and 9,642,844 (“the ’844 patent”); (collectively, “the …the ’973 patent and two claims of the ’844 patent, but not the other claims in those patents. Further…the patents-in-suit”). (Exhibits A–H.) This action arises under the Patent Laws of the United States, 35	External link to document
2017-09-13	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2; 8,486,973 B2; 8,835,459…13 September 2017 1:17-cv-01303 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-03-15	64	Notice of Service	Initial Invalidity Contentions Regarding U.S. Patent No. 10,016,403 filed by Teva Pharmaceuticals USA, Inc..…13 September 2017 1:17-cv-01303 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document